THERAPEUTIC
Technologies Available for License
Fluoride-Releasing
Dental Amalgam
Restorative
Material..........................................................013-98
A Novel Method to Modulate Inflammation.....................016-98
D-1
Like Dopamine Receptor
Activity Modifying Protein.................................................001-99
PCT Application Filed
Glucose-Dependent Insulinotropic Peptide For Use as an Osteotropic Hormone .............003-99, 010-01
PCT Application Filed
Novel
Analogs of Choline for
Neuroprotection and Cognitive Enhancement
in Neurodegenerative Disorders.....................................007-00
U.S. Patent Application 20030050316
A
Method of Therapeutic Intervention
to Enhance T Cell Immunity by Promoting
De Novo Production of Antigen
Specific Lymphocytes Using Synthetic Ligands............004-01
U.S. Patent Application 20030021796
Method for Treating Prostate Cancer.............................012-01
U.S. Patent Application 20020115613
Atypical
Neuroleptics Stimulate in Vivo
Neurogenesis in Adult Brain............................................008-02
U.S. Patent Pending 20030064082
PCT Application Filed
Novel Retinal Drug Delivery
and
Targeting....................................................................009-02
U.S. Patent Application 20040087664
PCT Application Filed
Use of P57/k1P2 to Evaluate
Agents for the Treatment and
Prevention of
Cancer........................................................021-02
U.S. Patent Application 20040191842
Cannabinoid
Receptor Interacting
Proteins
and Methods of Use..........................................005-03
U.S. Patent Application 20050095674
Campylobacter
Jejuni Outer Membrane
Protein
Vaccine.................................................................011-03
U.S. Patent Application 20050106159
Identification of a New Transport
System for Endogenous Opioid Peptides
in Mammals and Its Potential Use as a
Therapeutic Target for the
Management of Pain........................................................010-04
U.S. Patent Pending
A Novel Gene Associated with Type
1
Diabetes Susceptibility....................................................011-04
U.S. Patent Application 20050227272
Compositions and Methods for
the
Intracellular Disruption of VEGF and KDR
by RNA Interference and Intraceptors.............................013-04
U.S. Patent Pending
Virtual Surgical Systems and Methods..........................016-04
U.S. Patent Pending
A Novel Method of Total
Tympanic Membrane Replacement
Using Prefabricated Allograft Prosthesis.......................013-05
U.S. Patent Pending
Ancient Conserved
Domain Protein
(ACDP), a family of proteins for divalent
ion transport in mammalian cells.....................................018-05
U.S. Patent Pending
Effects of Green Tea
Polyphenols
on Autoimmune Disorders...............................................019-05
U.S. Patent Pending
Detergents Formulated
with Lipid Soluble
Green Tea Polyphenols....................................................002-06
U.S. Patent Pending
Novel Inhibitory Factor (NIF)............................................009-06
U.S. Patent Pending
Cloning of Two CDNA Sequences
for Mouse
PAR-4.............................................................013-06
U.S. Patent Pending
11-Nonyloxy-Undec-8(Z)-Eonic
Acid Derivates as Therapy for Renal
and Cardiovascular Diseases.......................................017-06
U.S. Patent Pending
Nitric Oxide Changes the Isoelectric
Charge on Sickle Hemoglobin......................................018-06
U.S. Patent Pending
Ectopic Expression of Gonadotropin
Releasing Hormone (GnRH) Receptors
In Adrenal Aldsoterone-Producing
Tumors causes Hyperaldosteronism............................019-06
U.S. Patent Pending
Role of Small Heat Shock
Proteins in Neurodegenerative
Diseases.........................................................................002-07
U.S. Patent Pending